The Life Sciences business of Lubrizol Corporation will feature a new medical device applications lab at MD&M West in Anaheim during February 5-7 at Booth #2401. Life Sciences is expanding its global development and manufacturing facilities, and the latest investment is a new state-of-the-art medical device applications lab in Brecksville, Ohio. This lab features applications testing, small-scale compounding as well as injection molding for long-term implantables. The 1,800-square foot facility will also focus on accelerated R&D, from polymers to device scale up and testing in a short period of time.

As a medical device development partner, Lubrizol Life Sciences helps customers from concept to commercialization by offering polymer customization, drug-eluting device development and contract manufacturing services. At MD&M West, Life Sciences will also highlight a strong presence in the interventional catheter, long-term implant and drug-eluting device markets. In addition, Life Sciences will unveil new dexamethasone-loaded polymers designed to minimize inflammation and help ensure the success of implantable medical devices.

To contact the author of this article, email